Skip to content

Fluid restriction versus 0.9% saline infusion in the treatment of hyponatraemia due to the syndrome of inappropriate antidiuresis in patients with pneumonia

A prospective randomised comparison of the effects of fluid restriction versus 0.9% saline infusion on plasma sodium and blood pressure in patients with pneumonia complicated by SIAD (syndrome of inappropriate antidiuresis)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN89527210
Enrollment
40
Registered
2018-01-29
Start date
2018-02-01
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Syndrome of inappropriate antidiuresis secondary to pneumonia Respiratory Syndrome of inappropriate antidiuresis secondary to pneumonia

Interventions

Once informed consent has been acquired, participants are randomised to either fluid restriction or 0.9% saline infusion using a computer generated randomisation table using random permutated blocks o

Sponsors

Beaumont Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age > 18 years 2. Eu-volemic 3. New asymptomatic hyponatraemia with plasma sodium 120 - 130 mmol/L 4. Biochemical confirmation of SIAD, including exclusion of adrenal insufficiency and hypothyroidism. 5. Radiographic confirmation of pneumonia 6. Clinical confirmation of pneumonia 7. Systolic blood pressure > 100 mmHg

Exclusion criteria

Exclusion criteria: 1. Symptomatic or severe hyponatraemia (plasma sodium < 120 mmol/L) 2. Volume depletion / hypovolaemia / systolic BP < 100 mmHg 3. CCF 4. Uncontrolled hyperglycemia 5. AKI 6. Diuretic therapy 7. Clinical imperative for intravenous fluids 8. Chronic hyponatraemia

Design outcomes

Primary

MeasureTime frame
1. Change in plasma sodium from baseline to day 4 (plasma sodium is measured using ion-selective electrode) 2. Change in blood pressure from baseline to day 4 (blood pressure is measured using amubulatory blood pressure monitoring on day 1 and day 3, and using office BP monitoring daily)

Secondary

MeasureTime frame
1. Proportion of patients achieving eunatraemia daily 2. Length of hospital stay, measured using the hospital database, up until time of discharge 3. Patient reported outcome (well-being), measured using the SF-12 and EQ-5D questionnaires, at baseline and day 4

Countries

Ireland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026